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Abstract
With increased global travel, unique diseases from different parts of the world pose a new
category of differential diagnosis, and an incubation period of different infectious diseases
helps narrow differential diagnosis to point to one specific etiology. The normal incubation
period of Plasmodium falciparum malaria is 7-40 days. We report a case of symptomatic P.
falciparum malaria that manifested four years after a visit to a malaria-endemic area in a 51year-old female patient. Our case illustrates the importance of a broad differential with
regard to infectious disease including remote travel history and raises questions of the survival
of P. falciparum for four years despite the administration of traditional chemoprophylactic
agents.
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Malaria is a mosquito-borne disease, transmitted by the Anopheles mosquito [1]. The normal
incubation period of Plasmodium falciparum malaria is 7-40 days, unlike other species such as P.
vivax and P. ovale, which may remain dormant in the liver for up to about four years. It is also
responsible for the most serious form of the disease [2]. However, in cases of partial immunity,
sickle cell disease or a history of chemoprophylaxis, the incubation period can become
prolonged and can lead to a late presentation of clinical symptoms from weeks to months. If
not diagnosed early and treated adequately, P. falciparum malaria can lead to life-threatening
complications, such as shock, lactic acidosis, seizures, and renal failure. The underlying
pathology is explained by the visible clumping of the erythrocytes in deep capillary beds. We
report a case of symptomatic P. falciparum malaria that manifested four years after a visit to a
malaria-endemic area in a 51-year-old woman. This patient lives in the United States and had
received appropriate malaria chemoprophylaxis four years prior to presentation. This
surprisingly long incubation period raises questions regarding the survival and fitness of P.
falciparum prior to disease manifestations and the rising resistance to traditional
chemoprophylactic agents.
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Case Presentation
Clinical presentation
A 51-year-old female from Liberia with a past medical history of hypertension,
gastroesophageal reflux, and appendectomy presented to the emergency department with
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fever, generalized body aches, malaise, and headache for two days. In the emergency
department, she was found to have a fever of 101.3 °F and tachycardia, with normal blood
pressure and respiratory status. She reported no other symptoms. Her last visit to Liberia was
four years ago. She denied any complications after her travel, including fever, fatigue, and
anemia. The patient reported chemoprophylaxis but was unable to remember the regimen. She
reported no travel outside of the New York area since then, including airports. She denied any
blood transfusions or any exposure to wooded areas or tick bites. She worked as a home health
aide; she denied smoking, alcohol, or illicit drug use.
Her laboratory tests revealed thrombocytopenia with a platelet count of 32,000 per microliter
(normal: 130,000-400,000 per microliter), leukopenia with a white blood cell count of 3,200 per
cubic milliliter (normal: 4,800-10,800 per cubic milliliter), and anemia with a hemoglobin of 9.2
g/dL (normal: 12.0-16.0 g/dL). Lactate dehydrogenase was 310 IU/L (normal: 50-242 IU/L) and
bilirubin 3.8 mg/dL (normal: 0.2-1.2 mg/dL), mostly indirect. Labs revealed elevated liver
function enzymes with alanine aminotransferase (ALT) and aspartate aminotransferase (AST)
being 57 and 67 U/L, respectively (normal: <41 U/L). Ultrasound of the liver was normal.
Peripheral blood smear showed P. falciparum on Giemsa stain with a parasitemia of 1.86%
(normal <1%; Figure 1). Molecular detection of Plasmodium using polymerase chain reaction
(PCR) yielded positive results. A diagnosis of malaria with Plasmodium falciparum was made.

FIGURE 1: Double dotted ring gametocytes shown by an arrow
inside a red blood cell - typical for Plasmodium falciparum
infection
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Chest X-ray was performed and was negative for any focal parenchymal opacities, pleural
effusions, or pneumothorax. No splenomegaly or hepatomegaly was evident on computed
tomography (CT) abdomen/ pelvis or abdominal ultrasound.

Treatment and management
The patient was treated with Malarone (atovaquone 1000 mg/proguanil 400 mg) once daily for 4
consecutive days. A decline in parasitemia was confirmed as the patient responded to
treatment; the last smear showed <1% parasitemia. Thrombocytes, lymphocytes, and lactate
dehydrogenase were closely monitored until they normalized. The patient was discharged home
with outpatient follow-up with an infectious disease specialist.

Discussion
There are five pathogenic species of Plasmodium causing malaria in humans: P. vivax, P.
falciparum, P. malariae, P. ovale, and Plasmodium knowlesi. P. vivax and P. falciparum are the two
most common species found in Africa. P. falciparum is the most lethal of all. The life cycle of
malaria parasites begins when an infected female Anopheles mosquito bites an uninfected
individual. Parasites stick to red blood cells and clump deformed erythrocytes in deep capillary
beds, predisposing to organ ischemia and shock, as well as tissue hypoxia and lactic acidosis.
A total of 2.4 billion people are at risk of stable or unstable Pl.falciparum transmission with 350
to 500 million clinical episodes and 1 million deaths annually [1]. According to the Center for
Disease Control, malaria can present after weeks to months after a history of travel to malariaendemic regions in the presence of chemoprophylaxis, especially in cases of non-falciparum
malaria species such as P. vivax and P. ovale. The normal incubation period for malaria is 7-40
days. It is shorter for falciparum species compared to non-falciparum species such as P. vivax
and P. ovale [3]. Chemoprophylaxis or partial immunity to malaria can prolong this incubation
period [4]. The longest incubation period found on a literature search of P. falciparum was eight
years after visiting an endemic area [5]. Our case report suggests that P. falciparum malaria can
present even after four years in a patient with a remote history of travel to an endemic region,
in spite of receiving chemoprophylaxis.
Repeated parasite exposure can lead to clinical immunity initially protecting from severe
consequences. However, as transmission rates decrease, the risk of infection also increases the
rates of severe disease due to the lack of functional immunity [6]. Outbreaks have been
reported with P. falciparum with reported infected United States marines in Liberia in 2003 [7].
In obtaining histories from patients, it is important to keep in mind remote travel histories as
they can indicate potential exposures as illustrated in this case.

Conclusions
From this case report, we conclude that our patient had P. falciparum malaria that she acquired
in Liberia four years prior to her clinical presentation. As P. falciparum malaria is a fatal disease,
it is crucial to have a high index of suspicion and investigate for disease in patients presenting
with fever, malaise, and thrombocytopenia, even with a remote history of travel to an endemic
region. Early appropriate management in these patients can prevent fatal complications and
even death.
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